#Brazil #Brasilia #Coronavirus
A test person died during a study on the Oxford vaccine by the pharmaceutical company AstraZeneca in Brazil.
A test person died during a study on the Oxford vaccine by the pharmaceutical company AstraZeneca in Brazil.
The Brazilian health surveillance authority, Anvisa, confirmed this to the German press agency on Wednesday. Brazilian media had previously reported on it. According to its own information, the surveillance authority had already been informed of this on Monday.
The recommendation is to continue testing. According to the television channel "CNN Brasil", the dead is a 28-year-old man from Rio de Janeiro who died of complications related to Covid-19.
The Brazilian newspaper "O Globo" reported, however, citing sources that did not want to be named for legal reasons that the volunteer in question had not received the vaccine, but a placebo.
Initially, neither the laboratory nor the test centers nor Anvisa officially commented on this question. AstraZeneca temporarily stopped the clinical trial for its promising corona vaccine in September - apparently not for the first time.
Up until then, the AZD1222 vaccine was one of the promising candidates among the potential corona vaccines. At that time, one of the participants had health problems. It is said to have been an inflammation in the spinal cord.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
